Covid-19 Impact on Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Standardization Of Cancer Treatment MRNA Vaccine
1.4.3 Individualized Cancer Treatment MRNA Vaccine
1.4.4 Infectious Disease Treatment MRNA Vaccine
1.4.5 Infection Prevention MRNA Vaccine
1.5 Covid-19 Implications on Market by Application
1.5.1 Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Infectious Disease
1.5.3 Cancer
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): mRNA Cancer Vaccines and Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the mRNA Cancer Vaccines and Therapeutics Industry
1.6.1.1 mRNA Cancer Vaccines and Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and mRNA Cancer Vaccines and Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for mRNA Cancer Vaccines and Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Covid-19 Implications on Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 mRNA Cancer Vaccines and Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key mRNA Cancer Vaccines and Therapeutics Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Market Size
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2015-2020)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2019
3.3 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
3.4 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
3.5 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2015-2020)
6.2 mRNA Cancer Vaccines and Therapeutics Key Players in North America (2019-2020)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2015-2020)
7.2 mRNA Cancer Vaccines and Therapeutics Key Players in Europe (2019-2020)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China mRNA Cancer Vaccines and Therapeutics Market Size (2015-2020)
8.2 mRNA Cancer Vaccines and Therapeutics Key Players in China (2019-2020)
8.3 China mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
8.4 China mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan mRNA Cancer Vaccines and Therapeutics Market Size (2015-2020)
9.2 mRNA Cancer Vaccines and Therapeutics Key Players in Japan (2019-2020)
9.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
9.4 Japan mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size (2015-2020)
10.2 mRNA Cancer Vaccines and Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India mRNA Cancer Vaccines and Therapeutics Market Size (2015-2020)
11.2 mRNA Cancer Vaccines and Therapeutics Key Players in India (2019-2020)
11.3 India mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
11.4 India mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America mRNA Cancer Vaccines and Therapeutics Market Size (2015-2020)
12.2 mRNA Cancer Vaccines and Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Moderna Therapeutics
13.1.1 Moderna Therapeutics Company Details
13.1.2 Moderna Therapeutics Business Overview and Its Total Revenue
13.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
13.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020))
13.1.5 Moderna Therapeutics Recent Development
13.2 CureVac
13.2.1 CureVac Company Details
13.2.2 CureVac Business Overview and Its Total Revenue
13.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
13.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
13.2.5 CureVac Recent Development
13.3 Translate Bio
13.3.1 Translate Bio Company Details
13.3.2 Translate Bio Business Overview and Its Total Revenue
13.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
13.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
13.3.5 Translate Bio Recent Development
13.4 BioNTech
13.4.1 BioNTech Company Details
13.4.2 BioNTech Business Overview and Its Total Revenue
13.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
13.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
13.4.5 BioNTech Recent Development
13.5 Sangamo Therapeutics
13.5.1 Sangamo Therapeutics Company Details
13.5.2 Sangamo Therapeutics Business Overview and Its Total Revenue
13.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
13.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
13.5.5 Sangamo Therapeutics Recent Development
13.6 Argos Therapeutics
13.6.1 Argos Therapeutics Company Details
13.6.2 Argos Therapeutics Business Overview and Its Total Revenue
13.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
13.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
13.6.5 Argos Therapeutics Recent Development
13.7 In-Cell-Art
13.7.1 In-Cell-Art Company Details
13.7.2 In-Cell-Art Business Overview and Its Total Revenue
13.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
13.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
13.7.5 In-Cell-Art Recent Development
13.8 eTheRNA
13.8.1 eTheRNA Company Details
13.8.2 eTheRNA Business Overview and Its Total Revenue
13.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
13.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
13.8.5 eTheRNA Recent Development
13.9 Ethris
13.9.1 Ethris Company Details
13.9.2 Ethris Business Overview and Its Total Revenue
13.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
13.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
13.9.5 Ethris Recent Development
13.10 Tiba Biotechnology
13.10.1 Tiba Biotechnology Company Details
13.10.2 Tiba Biotechnology Business Overview and Its Total Revenue
13.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
13.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
13.10.5 Tiba Biotechnology Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. mRNA Cancer Vaccines and Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
Table 3. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Standardization Of Cancer Treatment MRNA Vaccine
Table 6. Key Players of Individualized Cancer Treatment MRNA Vaccine
Table 7. Key Players of Infectious Disease Treatment MRNA Vaccine
Table 8. Key Players of Infection Prevention MRNA Vaccine
Table 9. COVID-19 Impact Global Market: (Four mRNA Cancer Vaccines and Therapeutics Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for mRNA Cancer Vaccines and Therapeutics Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for mRNA Cancer Vaccines and Therapeutics Players to Combat Covid-19 Impact
Table 14. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2015-2020)
Table 18. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. mRNA Cancer Vaccines and Therapeutics Market Growth Strategy
Table 24. Main Points Interviewed from Key mRNA Cancer Vaccines and Therapeutics Players
Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 26. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2015-2020)
Table 27. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2019)
Table 28. Global mRNA Cancer Vaccines and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
Table 31. Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 34. Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Type (2015-2020)
Table 35. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2021-2026)
Table 36. Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Application (2015-2020)
Table 37. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Application (2021-2026)
Table 39. North America Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2019-2020)
Table 41. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. North America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2015-2020)
Table 43. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. North America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2015-2020)
Table 45. Europe Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2019-2020)
Table 47. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2015-2020)
Table 49. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2015-2020)
Table 51. China Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2019-2020) (Million US$)
Table 52. China Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2019-2020)
Table 53. China mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. China mRNA Cancer Vaccines and Therapeutics Market Share by Type (2015-2020)
Table 55. China mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. China mRNA Cancer Vaccines and Therapeutics Market Share by Application (2015-2020)
Table 57. Japan Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2019-2020)
Table 59. Japan mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan mRNA Cancer Vaccines and Therapeutics Market Share by Type (2015-2020)
Table 61. Japan mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan mRNA Cancer Vaccines and Therapeutics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2019-2020)
Table 65. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Share by Type (2015-2020)
Table 67. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Share by Application (2015-2020)
Table 69. India Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2019-2020) (Million US$)
Table 70. India Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2019-2020)
Table 71. India mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. India mRNA Cancer Vaccines and Therapeutics Market Share by Type (2015-2020)
Table 73. India mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. India mRNA Cancer Vaccines and Therapeutics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players mRNA Cancer Vaccines and Therapeutics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players mRNA Cancer Vaccines and Therapeutics Market Share (2019-2020)
Table 77. Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2015-2020)
Table 79. Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2015-2020)
Table 81. Moderna Therapeutics Company Details
Table 82. Moderna Therapeutics Business Overview
Table 83. Moderna Therapeutics Product
Table 84. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 85. Moderna Therapeutics Recent Development
Table 86. CureVac Company Details
Table 87. CureVac Business Overview
Table 88. CureVac Product
Table 89. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 90. CureVac Recent Development
Table 91. Translate Bio Company Details
Table 92. Translate Bio Business Overview
Table 93. Translate Bio Product
Table 94. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 95. Translate Bio Recent Development
Table 96. BioNTech Company Details
Table 97. BioNTech Business Overview
Table 98. BioNTech Product
Table 99. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 100. BioNTech Recent Development
Table 101. Sangamo Therapeutics Company Details
Table 102. Sangamo Therapeutics Business Overview
Table 103. Sangamo Therapeutics Product
Table 104. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 105. Sangamo Therapeutics Recent Development
Table 106. Argos Therapeutics Company Details
Table 107. Argos Therapeutics Business Overview
Table 108. Argos Therapeutics Product
Table 109. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 110. Argos Therapeutics Recent Development
Table 111. In-Cell-Art Company Details
Table 112. In-Cell-Art Business Overview
Table 113. In-Cell-Art Product
Table 114. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 115. In-Cell-Art Recent Development
Table 116. eTheRNA Business Overview
Table 117. eTheRNA Product
Table 118. eTheRNA Company Details
Table 119. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 120. eTheRNA Recent Development
Table 121. Ethris Company Details
Table 122. Ethris Business Overview
Table 123. Ethris Product
Table 124. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 125. Ethris Recent Development
Table 126. Tiba Biotechnology Company Details
Table 127. Tiba Biotechnology Business Overview
Table 128. Tiba Biotechnology Product
Table 129. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (Million US$)
Table 130. Tiba Biotechnology Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Standardization Of Cancer Treatment MRNA Vaccine Features
Figure 3. Individualized Cancer Treatment MRNA Vaccine Features
Figure 4. Infectious Disease Treatment MRNA Vaccine Features
Figure 5. Infection Prevention MRNA Vaccine Features
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Infectious Disease Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 11. Global mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2019
Figure 16. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2019
Figure 18. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 27. CureVac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 29. Translate Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 31. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 33. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 35. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 37. In-Cell-Art Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 39. eTheRNA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 41. Ethris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 43. Tiba Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs